Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fengyang Lin"'
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0239408 (2020)
Empirical research on migration has historically been fraught with measurement challenges. Recently, the increasing ubiquity of digital trace data-from mobile phones, social media, and related sources of 'big data'-has created new opportunities for t
Externí odkaz:
https://doaj.org/article/fc9c4e15d5d640df8ceda7fe99dcc891
Publikováno v:
Studies in health technology and informatics. 290
Sample size is an important indicator of the power of randomized controlled trials (RCTs). In this paper, we designed a total sample size extractor using a combination of syntactic and machine learning methods, and evaluated it on 300 Covid-19 abstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47cd73460a9a2adcaa0de85eab55ce8b
https://pubmed.ncbi.nlm.nih.gov/35673090
https://pubmed.ncbi.nlm.nih.gov/35673090
Sample size is an important indicator of the power of randomized controlled trials (RCTs). In this paper, we designed a total sample size extractor using a combination of syntactic and machine learning methods, and evaluated it on 300 Covid-19 abstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e5943c48a6c24db54ead33a47c453bf
https://doi.org/10.3233/shti220151
https://doi.org/10.3233/shti220151
Autor:
Chunhua Weng, Betina Ross S. Idnay, Jae Hyun Kim, Fengyang Lin, Xinyi Wei, Alex Butler, Hao Liu, Yingcheng Sun, Latoya A. Stewart, Qingyin Ge, Cong Liu, Chi Yuan
Publikováno v:
Journal of the American Medical Informatics Association
Journal of the American Medical Informatics Association : JAMIA
Journal of the American Medical Informatics Association : JAMIA
Clinical trials are the gold standard for generating reliable medical evidence. The biggest bottleneck in clinical trials is recruitment. To facilitate recruitment, tools for patient search of relevant clinical trials have been developed, but users o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84176a25e547f587263fb70a609e740
https://doi.org/10.1093/jamia/ocaa304
https://doi.org/10.1093/jamia/ocaa304
Publikováno v:
Medinfo; 2021, Vol. 290, p617-621, 5p
Autor:
Kang Yu, Jianhua Feng, Nina Lu, Chongyun Xing, Fengyang Lin, Na Wang, Liyuan Tang, Yifen Shi, Yongyong Ma, Yi Chen, Lan Sun
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 25(8)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only available curative treatment for patients with β-thalassemia major (β-TM). However, the problem of finding a suitable sibling donor with well-matched human leukocyte antigens is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e30c4c5591d9e8e6108cde937cc5a8f
https://pubmed.ncbi.nlm.nih.gov/30951841
https://pubmed.ncbi.nlm.nih.gov/30951841